Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02546066n
Noun Concept
PT
No term available
EN
Ponatinib, sold under the brand name Iclusig, is a medication developed by ARIAD Pharmaceuticals for the treatment of chronic myeloid leukemia and Philadelphia chromosome–positive acute lymphoblastic leukemia. Wikipedia
Relations
Sources
IS A
composto insaturado
MEDICAL CONDITION TREATED
leucemia mieloide aguda
tumor estromal gastrointestinal
PHYSICALLY INTERACTS WITH
RET
ABL1
SUBJECT HAS ROLE
inibidor da tirosina-quinase
inibidor da proteína quinase
antineoplásico
USE
medicamento

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License